Last edition
News about "hypochondroplasia"
BioMarin Reports Positive Phase 3 VOXZOGO Results in Hypochondroplasia
BioMarin reports positive phase 3 VOXZOGO results in children with hypochondroplasia, showing significant improvements in growth measures and supporting Food and Drug Administration (FDA) supplemental New Drug Application (sNDA).
Hypochondroplasia | 11/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members